Jeffrey M. Lemons

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison et al. · Journal of Clinical Oncology · 2018 · 574 citations

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma

Aditya Juloori, Rohan Katipally, Jeffrey M. Lemons et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 71 citations

Hepatology, Radiation Therapy, Medicine +10

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial

Jason J. Luke, Benjamin E. Onderdonk, Sandeep R. Bhave et al. · Clinical Cancer Research · 2020 · 67 citations · Full text

Anatomical contouring variability in thoracic organs at risk

Ross McCall, Matthew Taylor, Nishele Lenards et al. · Medical dosimetry · 2016 · 17 citations

Gross Anatomy, Medical Imaging, Anatomical Variations +10

The ADscopal Effect? Control of Partially Irradiated Versus Completely Irradiated Tumors on a Prospective Trial of Pembrolizumab and SBRT Per NRG-BR001

Jeffrey M. Lemons, Jason J. Luke, Linda Janisch et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 14 citations · Full text

Radiation Therapy, Medicine, Adscopal Effect +7